FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.

Awarded to CREATIVE BIOLABS INC

PIID 75N91021P00496US · USAspendingBiotechnology & Pharmaceuticals
$33.6K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$33,590sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateJun 8, 2021
Company legal name
CREATIVE BIOLABS INC
UEI / CAGE
V595TMBX2117 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
45-1 RAMSEY RD, SHIRLEY, SUFFOLK, NY, 11967
Place of performance
SHIRLEY, SUFFOLK, NY, 11967
Source last modified
Nov 3, 2026

Description

PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.

    US · usaspendingSource ↗
  2. Value increased

    PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.

    US · usaspending$33.6KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Jun 8, 20210Not reported$33,590.00Not reportedNot reportedPURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.USAspending ↗